Pharmaceutical Executive Issue Alert Having trouble viewing this email? Click here
Web Version | Share with a colleague | View Digital Edition | Subscribe
In our September issue of Pharmaceutical Executive
FEATURES

Cover Story
 Pharm Exec's Emerging Pharma Leaders
Pharm Exec's 9th annual list of rising industry leaders illustrates how the deployment of essential human capital has changed in line with a business model that is no longer static and predictable–or complacent.
Europe
Brexit Report: What's Next for the Industry?
Michael Swanick, Jo Pisani, Tamora Saunders, Ben Comer
As the UK exits the European Union, pharma should prepare for changes by identifying key business issues, mitigating risks and creating plans for multiple scenarios.
Roundtable
 Patient-Centered Strategies for Clinical Trials & Treatments
William Looney
Pharm Exec and inVentiv Health convened a roundtable discussion at the 2016 ASCO meeting to review the use of patient-reported outcomes (PRO) in the clinical trial and commercialization space.
From the Editor
 Rise of the Vox Populi
 William Looney
Big pharma has become increasingly vulnerable to larger geopolitical and macroeconomic risks—a realization that has slowly creeped into their business planning.
ALSO IN THIS ISSUE
 Opioid Epidemic: More Finger Pointing at the Industry
Jill Wechsler
Traditional sales and pricing practices face legal challenges and political backlash .
 
WEBCASTS
Optimizing Real-World Evidence Programs to Generate Value
Considering Biosimilars: A Panel Discussion Exploring Perceptions and Potential Adoption
Why Patient Support Programs Need a Personal Approach
Understanding the Chronic Disease Patient Journey in Emerging Markets
Four Strategies You Need to Maximize the Value of Your Data
 
Download the
issue:
 
image

Pharmaceutical Executive is free to qualified subscribers. To subscribe, click here.

Click here to contact the Pharmaceutical Executive sales team.
Twitter LinkedIn